The average age of liver transplant donors and recipients has increased over the years.
Independent of the cause of liver disease, older candidates have more comorbidities, higher …

Donor evaluation is a critical step before proceeding with liver transplantation (LT) in both
deceased donor LT (DDLT) and living donor LT (LDLT). A good, healthy graft is necessary …

Background Although surgical technique in living donor liver transplantation (LDLT) has
evolved with a focus on donor safety and recipient challenges, the donor selection criteria …

Post‐transplant lymphoproliferative disorders (PTLDs) are life‐threatening neoplasms after
organ transplantation. Because of their rarity and multiple grades of malignancy, the …

Antibody-mediated rejection (AMR) is a refractory rejection after ABO blood-type
incompatible (ABOi) or donor-specific antibody (DSA)-positive liver transplantation (LT) …

Abstract Background and Aims Liver transplantation (LT) is the treatment of end‐stage non‐
alcoholic liver disease (NAFLD), that is decompensated cirrhosis and/or complicated by …

Adult‐to‐adult living donor liver transplantation (ALDLT) using small‐for‐size grafts
(SFSGs), ie, a graft with a graft‐to‐recipient weight ratio (GRWR)< 0.8%, has been a …

There is a consensus that portal venous pressure (PVP) modulation prevents portal
hypertension (PHT) and consequent complications after adult‐to‐adult living donor liver …

Background. Several studies reported favorable outcomes of small-for-size grafts with graft-
to-recipient weight ratio (GRWR)< 0.8% in living-donor liver transplantation (LDLT) …

Knowledge of living donor liver transplantation (LDLT) for autoimmune liver diseases
(AILDs) is scarce. This study analyzed survival in LDLT recipients registered in the …